|
|
|
 |
Twitter Inc. shook hands with Google Inc. yesterday wherein the search engine will start indexing the 140-characters tweets of Twitter’s 284 million monthly users
Read More... |
| |
 |
Bidness ETC takes an in-depth look into Microsoft’s and Fitbit’s latest wearable fitness tech
Read More... |
| |
 |
The industry is buzzing with rumors and speculation about what Apple might have in store for its music service
Read More... |
| |
 |
MKM Partners analyst, Michael Genovese, raised his price target on Cisco by $2, while reiterating a Neutral rating
Read More... |
| |
 |
Tableau Software announced 4Q financial performance on Thursday, beating analyst estimates for revenue and EPS
Read More... |
| |
 |
Glu Mobile stock was upgraded at Needham & Company, following strong 4Q results
Read More... |
| |
 |
Twitter CEO Dick Costolo has acknowledged the detrimental threat from trolls on the social media platform, and has stated that the company will work harder to combat the issue
Read More... |
| |
 |
Twitter will announce earnings results for the fourth quarter of its fiscal year 2014 (4QFY14) after the markets close on February 5
Read More... |
| |
 |
Some of the most interesting content from GoPro makes its way to Roku customers
Read More... |
| |
 |
9to5Mac sources disagree with iGen.fr’s claims that Apple has scheduled an event on February 24 to showcase Apple Watch and the 12-inch MacBook Air
Read More... |
| |
 |
Google is all set to build the Google Glass up from scratch, with iPod visionary Tony Fadell and jewelry designer Ivy Ross at the helm with a mission to correct the mistakes of the past
Read More... |
| |
 |
Apple may not be hosting the Apple Watch launch event in February after all. New reports suggest that the tech giant will launch the gadget in March
Read More... |
| |
 |
WEDBUSH has reiterated its Neutral rating for Twitter stock ahead of its earnings report expecting good results but has cited concerns about user engagement on the platform
Read More... |
| |
 |
Apple is not known for manufacturing cars, but recently obtained patents raised a few eyebrows. Bidness Etc sheds light on the matter
Read More... |
| |
 |
Bidness Etc explores some of the best iPhone apps to be released in 2015 so far
Read More... |
| |
 |
Latest reports reveal Microsoft has made a move to acquire popular startup Sunrise Calendar. Bidness Etc explores Microsoft's recent push into mobile development
Read More... |
| |
 |
Morgan Stanley recently commented on Windows 10’s impact on Microsoft’s financial statements
Read More... |
| |
|
|
 |
JP Morgan lowers target price on Navistar International stock to $28, downgrades the stock to Underweight
Read More... |
| |
|
|
 |
Michael Kors reported its 4Q results today, beating earnings and revenues. However, the stock is falling on a weak guidance for the next quarter
Read More... |
| |
 |
In a new report, Credit Suisse analysts have named Tesla as the top stock in the automobile industry. They believe the automaker is shaping the future of electric cars
Read More... |
| |
 |
Yum! Brands reported 4Q results yesterday, missing analysts’ EPS estimate due to the controversy surrounding one of its suppliers in China
Read More... |
| |
 |
Pacific Crest Securities recently met with the managements of Alibaba and Baidu in China and is bullish on both companies. Here’s why
Read More... |
| |
 |
Ford is finding it hard to match strong demand for its F-150 truck. Tesla is facing a similar problem with its Model S
Read More... |
| |
 |
Bidness Etc takes a look at Credit Suisse’s top picks in the consumer sector
Read More... |
| |
 |
Under Armour on Wednesday announced upbeat fourth-quarter and full-year results and unveiled two new acquisitions of fitness app-based companies
Read More... |
| |
 |
Credit Suisse recently released a report reiterating its bearish stance for C.H. Robinson following a bleak FY15 outlook released by the company as part of the fourth-quarter results
Read More... |
| |
 |
Arizona State House Committee has forwarded a bill that proposes lifting of the ban on Tesla from directly making sales to consumers
Read More... |
| |
 |
Bidness Etc looks at Ford Motor Company’s decision to launch a new taxi, called Transit Connect Taxi, in Hong Kong
Read More... |
| |
 |
A Consumer Reports survey shows Tesla trumped all other automakers in terms of servicing and repairs
Read More... |
| |
 |
Bidness Etc looks at SpaceX’s second attempt to safely land the Falcon 9 rocket on a floating platform in the Atlantic Ocean
Read More... |
| |
 |
Ford has kick-started 2015 with record sales for the month of January, driven largely by the new all-aluminum F-150 pickup series
Read More... |
| |
 |
Bidness Etc takes a look at the speculations swirling in the market that RadioShack may be filing for bankruptcy as soon as today
Read More... |
| |
 |
Wells Fargo reduces its 12-month price target range on Ralph Lauren stock from $185-196 to $155-164, after the company missed expectations in its quarterly financial results
Read More... |
| |
|
|
 |
Bidness Etc takes a look at reasons behind Weatherford International’s decision to lay off 5,000 workers
Read More... |
| |
 |
Bidness Etc takes a look at the reasons provided by Credit Suisse analysts for selecting Kinder Morgan stock as one of the top investment ideas of 2015
Read More... |
| |
 |
Bidness etc takes a look at the challenges be faced by the new CEO of Petrobras
Read More... |
| |
 |
Bidness Etc takes a look at how sell-side analysts are losing trust on Transocean, revising down their ratings and price targets on its stock
Read More... |
| |
 |
Bidness Etc looks at the reasons provided by Fitch Ratings to downgrade the outlook of Transocean stock from Stable to Negative. Also, how Fitch has rated the debt of the oil company is discussed below
Read More... |
| |
 |
Petrobras CEO Maria das Graças Silva Foster has finally decided to step down from her position. Bidness Etc discusses the top three potential candidates to succeed her and why they might be the right choice
Read More... |
| |
 |
Bidness Etc looks at Merrill Lynch’s reaction to BP’s fourth-quarter earnings release and the quarterly loss reported by the oil giant
Read More... |
| |
 |
Bidness Etc looks at the report released by Credit Suisse analyst regarding the fourth-quarter results of Exxon Mobil, and why the sell-side sees an 11% downside on the stock
Read More... |
| |
|
|
 |
A higher-than-expected subscriber churn in the most recent quarter has caused Verizon to rethink its premium pricing strategy
Read More... |
| |
 |
Sprint posted better-than-expected revenue growth after subscriber additions improved. The carrier recorded a loss of $2.54 billion, compared to 192 million loss it recorded in the previous quarter
Read More... |
| |
 |
Vodafone Group has posted the smallest revenue decline in the past 10 quarters due to the recovery of its core European market
Read More... |
| |
 |
Frontier Communications’ dividends have fallen 60% since its purchase of Verizon’s assets in 2010. Another deal with the carrier might deliver a huge blow to Frontier
Read More... |
| |
|
|
 |
Pfizer will acquire Hospira for $17 billion, in hopes to strengthen the former's biosimilar pipeline, by the second half of 2015
Read More... |
| |
 |
Bidness ETC highlights recent insider selling activity for the stocks of Gilead Sciences, LinkedIn, and Boeing
Read More... |
| |
 |
Despite posting exceptional results, Gilead stock was 8.2% down during yesterday’s trading, mainly due to the company’s hefty discounts for its blockbuster hepatitis C treatments
Read More... |
| |
 |
The breach compromised names, social security numbers of customers and employees of Anthem, which serves nearly 69 million people through its affiliated companies
Read More... |
| |
 |
Amgen’s investigational biosimilar version of AbbVie’s Humira showed similar safety and efficacy in a Phase III study for treating moderate-to-severe rheumatoid arthritis
Read More... |
| |
 |
Allergan’s profits peaked as sales shot up during the fourth quarter of fiscal 2014, ahead of acquisition by Actavis plc
Read More... |
| |
 |
Merck announced that the FDA has withdrawn its breakthrough therapy designation for the company’s hepatitis C treatment drug
Read More... |
| |
댓글 없음:
댓글 쓰기